BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy Special editorial highlights the...
BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“Entero” or the “Company”), a late clinical-stage...
BOCA RATON, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.063 | -15.1807228916 | 0.415 | 0.45 | 0.28 | 149603 | 0.35642666 | CS |
4 | -0.004 | -1.12359550562 | 0.356 | 0.46 | 0.2501 | 227317 | 0.40441301 | CS |
12 | -1.408 | -80 | 1.76 | 1.84 | 0.185 | 649059 | 0.37948068 | CS |
26 | -2.608 | -88.1081081081 | 2.96 | 3.16 | 0.185 | 454505 | 0.41571485 | CS |
52 | -2.608 | -88.1081081081 | 2.96 | 3.16 | 0.185 | 454505 | 0.41571485 | CS |
156 | -2.608 | -88.1081081081 | 2.96 | 3.16 | 0.185 | 454505 | 0.41571485 | CS |
260 | -2.608 | -88.1081081081 | 2.96 | 3.16 | 0.185 | 454505 | 0.41571485 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.